About Us

Dr. Christian van den Bos

Mares Ltd. was founded by Christian van den Bos in 2007 to serve the biotech- and pharmaceutical industry. He serves as ist director.


Previously, he experienced as international R&D Manager, he has been actively developing and up-scaling ATMPs for more than 20 years, including 10 years of US-based professional activities. He served in responsible scientific and managerial positions at Lonza (Germany), Cytograft (USA), Symetis (Switzerland, Germany), ViaCell (USA), Kourion (Germany), Spectra Stable Isotopes (USA), Martek Biosciences (USA) and Osiris Therapeutics (USA). Christian enjoyed post-doctoral training at Cold Spring Harbor Laboratories (USA), obtained a Ph.D. from the University of Muenster (Germany), and a degree of Master of Science from the university of Oxford (UK).


In his career, Christian contributed to all stages of drug development – from early research to commercial manufacturing. His recent track record includes:


  • Planning & executing aseptic manufacturing plants in Germany, USA and India
  • Obtaining an import permit (GMP approval) for a tissue engineering product (US/Germany)
  • Obtaining Ethics Committee approval for a multi-center, multi-indication clinical trial, phase I/II (Germany)
  • Preparing a investigators brochure (Germany)
  • Preparing a clinical trial application for a tissue engineered product (Germany)
  • Developing processes for scale-up of relevant production processes
  • Developing processes enhancing the potency of cell based products


Christian van den Bos has been recognized as a Qualified Person (QP) for ATMPs according to EU requirements.





Mares Ltd.
Münsterstr. 87
48268 Greven · Germany

VAT-ID: DE 274756617

United Kingdom

Mares Ltd.
69 Great Hampton St
Birmingham B18 6EW · UK


Mares Ltd. is registered in England & Wales
Company No.: 5959684

Phone: +49 2571 9588001
Fax: +49 2571 9588003
E-Mail: contactNOSPAM@maresltd.eu


Director / Geschäftsführer: Dr. rer. nat. R. Christian van den Bos, M.Sc. (Oxon)